Pierre Guyot Joins SpineGuard Board

SpineGuard is announcing that Pierre Guyot has been appointed to its Board of Directors. Guyot has served as chief executive officer and Board Director of Mölnlycke Healthcare since 2007, leading the development of this Swedish corporation both in terms of growth and profitability. Throughout the last seven years, Mölnlycke has steadily grown into an over €1 billion revenue company and undisputed leader in many of its markets. Earlier in his career, Guyot held executive management positions at Becton Dickinson, Johnson & Johnson, and Boston Scientific.

“I am delighted that Pierre has accepted to join SpineGuard. Having worked with him at Boston Scientific for a number of years, I know he will bring us invaluable strategic guidance as we expand commercially and develop new clinical applications for our PediGuard technology platform, ” said Pierre Jérôme, co-founder and chief executive officer of SpineGuard, in the January 2, 2014 news release.

“I am very excited by the opportunity to join SpineGuard, a truly innovative company with a disruptive technology value proposition. I strongly believe that the PediGuard technology platform offers compelling multi-faceted benefits to both patients and health care practitioners. I look forward to adding value to the Board of Directors and contributing to the further successful development of the PediGuard platform, ” said Guyot.

“We are very pleased to welcome a leader of Pierre Guyot’s caliber to the Board of SpineGuard. Pierre’s track record on successfully developing medical technology divisions and companies into dynamic growth businesses makes him an excellent addition to the SpineGuard Board. Pierre’s expertise and leadership will be incredibly beneficial to SpineGuard, our employees and our shareholders, ” added Alan Olsen, chairman of SpineGuard.

Guyot told OTW, “First and foremost, I am delighted to join the Board of Spineguard and contribute to the further growth and potential development of the PediGuard technology platform. My initial personal priorities will be to establish a constructive and challenging relationship with the management team and the other Board members. In addition, and as part of my induction process which will start with the attendance of the first board meeting in January 2014, I will ensure I take a ‘deep dive’ to familiarize myself with the clinical environment by attending few procedures and interacting with surgeons.”